Cubist Systematic Strategies’s Strata Critical Medical Inc SRTA Stock Holding History

Cubist Systematic Strategies’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$368K	Buy	+72,781	New	+$322K	﹤0.01%	2422
2024 Q3	–	Sell	-38,651	Closed	-$135K	–	3004
2024 Q2	$135K	Buy	38,651 +16,922	+78%	+$56.4K	﹤0.01%	2581
2024 Q1	$61.9K	Buy	+21,729	New	+$67K	﹤0.01%	3347
2023 Q3	–	Sell	-20,525	Closed	-$80.9K	–	3358
2023 Q2	$80.9K	Buy	+20,525	New	+$65.1K	﹤0.01%	3034
2022 Q4	–	Sell	-58,978	Closed	-$238K	–	4252
2022 Q3	$238K	Sell	58,978 -16,041	-21%	-$82.4K	﹤0.01%	3655
2022 Q2	$335K	Buy	75,019 +37,616	+101%	+$271K	﹤0.01%	3358
2022 Q1	$318K	Sell	37,403 -99,933	-73%	-$702K	﹤0.01%	2808
2021 Q4	$1.21M	Buy	137,336 +69,436	+102%	+$660K	0.01%	1770
2021 Q3	$706K	Buy	+67,900	New	+$593K	0.01%	1789

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's SRTA Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Strata Critical Medical Inc (SRTA) in Q3 2025: 72,781 shares worth $368K. The stake represents ﹤0.01% of the portfolio and ranks #2422 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in SRTA as recently as Q2 2024.

Cubist Systematic Strategies first reported a position in SRTA in Q3 2021 and has held it in 9 quarters since. The position peaked at $1.21M in Q4 2021. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

Cubist Systematic Strategies held 72,781 shares of Strata Critical Medical Inc worth $368K as of Q3 2025.
Strata Critical Medical Inc was a new Cubist Systematic Strategies position in Q3 2025.
Strata Critical Medical Inc made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2422 holding.
Cubist Systematic Strategies first reported a position in Strata Critical Medical Inc in Q3 2021 and has held it in 9 quarters since.
Cubist Systematic Strategies's Strata Critical Medical Inc position peaked at $1.21M in Q4 2021.
137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.